Figure 1.
Diagram of patient testing and trial allocation on ATTACC. The eligible biomarker population was defined as a biomarker result that met an ATTACC-companion trial eligibility.
Diagram of patient testing and trial allocation on ATTACC. The eligible biomarker population was defined as a biomarker result that met an ATTACC-companion trial eligibility.